SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Firsthand Technology Value Fund, Inc. (SVVC) (CIK 0001495584) (SVVC) — Feb 15, 2013

Firsthand Technology Value Fund, Inc. (SVVC) (CIK 0001495584)
Date: Feb. 15, 2013 · CIK: 0001495584 · Accession: 0000000000-13-008939

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-179606, 333-186158, 814-00830

Date
February 14, 2013
Author
Not clearly detected
Form
UPLOAD
Company
Firsthand Technology Value Fund, Inc. (SVVC) (CIK 0001495584)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.20S49 DIVISION OF INVESTMENT MANAGEMENT February 14, 2013 David Hearth, Esq. Paul, Hastings, Janofsky & Walker LLP 55 Second Street, 24th Floor San Francisco, California 94105-3441 RE: Firsthand Technology Value Fund, Inc. ("Fund") File Nos.: 333-186158 and 814-00830 Dear Mr. Hearth: The Fund filed a shelf registration statement on January 23, 2013 under which it may offer up to $10,000,000 of its common stock ("Securities") under the Securities Act of 1933 ("1933 Act"). The Fund is a business development company ("BDC") regulated under the Investment Company Act of 1940 ("1940 Act"). The Fund expects to file a pre-effective amendment to the registration statement that will increase the total offering price of the shares covered by the registration statement. The Securities may be offered at prices and on terms to be disclosed in one or more supplements to this prospectus. Your letter represented that the registration did not contain any material changes from the disclosure included in the Fund's shelf registration statement on Form N-2 (File No. 333-179606), initially filed with the Commission on February 21, 2012 and declared effective, as amended, on April 19, 2012 ("Old Registration"), except for the soon to be completed inclusion of audited financial statements and related financial data for the fiscal year ended December 31, 2012. The registration statement makes non-material disclosure changes for various purposes including disclosure of updated portfolio holdings, business activities and market information, such as net asset value and stock price as of a more recent date. Your letter further states that there are no problem areas warranting special attention and there are no new investment techniques or policies disclosed in the registration statement. Pursuant to Securities Act Release No. 6510 and in reliance upon the representations contained in your letter of February 5, 2013, we performed a limited review of the Fund's registration statement. Whenever a comment is made in one location, you should consider it applicable to all similar

disclosure appearing elsewhere in the registration statement (including all future prospectus supplements). We have the following comments. 1. We note that material portions of the filing are incomplete and that most exhibits and the financial statements are omitted. We may have additional comments on such portions when you complete them in a pre- effective amendment, on disclosures made in response to this letter, on information supplied supplementally, or on exhibits added in any pre- effective amendments. Cover Page 2. The Fund intends to invest at least 80% of its total assets in equity securities of technology companies. However, a Form 8-K filed on January 14 contains a press release issued by the Fund that states "(tJhe Fund also announced that, as of December 31, 2012, preliminary gross assets of the Fund were approximately $197 million, or $23.03 per share, including cash of approximately $15.99 per share". Thus, since it appears that the Fund held approximately 69% of its assets in cash, please explain how the Fund will comply with its 80% test, especially in view of its potential cash increase from the proceeds of this offering. The "Use of Proceeds" section on page 18 should be expanded accordingly. 3. The staff notes that some equity positions held by the Fund may be subject to extensive speculation with regard to future potential for an initial public offering. This public speculation may cause Fund's shares to trade at significant premiums immediately prior to a portfolio company's initial public offering. This would appear to occur when Fund shares are used as a surrogate for portfolio company shares. However, once the shares of the portfolio company become widely available to the public, any premium that the Fund trades at may be reduced or eliminated. Please be aware that depending on the Fund's market premium and the depth of public speculation regarding its portfolio companies, the Fund may need to add disclosure similar to that on the cover page of the Old Registration1. Please 1 The cover page of the Old Registration states, "(aJs of March 31, 2012, our shares traded at a significant premium to our net asset value per share. However, only relatively recently the Company's common stock had traded at a substantial discount to its net asset value. If our premium decreases after this offering, investors who purchase shares in this offering would experience losses. The premium may also be reduced or eliminated if and when certain of our portfolio companies complete initial public offerings. As of December 31, 2011, our net asset value per share was $23.92 per share. Assuming a public offering price of $34.79 per share, which was the last reported sales price for our common stock on the NASDAQ Global Market on April 16, 2012, purchasers in this offering will experience immediate and substantial dilution in net asset value of approximately $8.37 per share. See "Dilution" for more information. In addition, the companies in which we invest are subject to special risks."

explain in your response letter how the Fund will address/monitor this issue in its prospectus supplements. Page 7 4. The table on this page has a column captioned "Percent of Long-Term Investments" with respect to the Fund's top five equity holdings. This presentation appears to eliminate the Fund's large cash position. Thus, it might give the appearance that the top five holdings are a more significant part of the Fund's investment portfolio than they actually are. Please revise the disclosure to take into account the Fund's cash position. Page 12 5. Substitute the word "do" for the word "may" in the last sentence of the last paragraph on this page. Page 14 6. Please ensure that in any prospectus supplement the Example will be adjusted for any sales load. Page 16 7. The Fund should provide some cautionary footnote language for investors as to the strong probability that it will be unlikely to maintain such large premiums to NAV in the future (e.g., 93.9% and 64.9%) with respect to the chart on this page. Page 22 8. If true, insert the term "equity" before the word "securities" in the first sentence of the third full paragraph discussing valuation. Page 37 9. Please inform the staff whether the Board will review and approve in advance the valuation methodology of any third-party pricing service it uses and confirm that the Board will regularly review the historical accuracy of its fair value methodologies. See Release No. IC-26299; "Compliance Programs of Investment Companies and Investment Advisers," (December 17, 2003)2. 2 The Release states that Rule 38a- 1 requires Funds to provide a methodology or methodologies by which the fund determines the current fair value of the portfolio security, and to "regularly review the

Page 43 10. Please explain the caption and disclosure for "companies that have developed leading market positions within their respective markets" in light of the Fund's stated exposure to micro-cap companies. Revise and develop the disclosure as needed. 11. Expand the disclosure related to the penultimate sentence of the last paragraph to explain why the Fund believes strategic sales are more likely than initial public offerings. Page 44 12. Please revise the disclosure regarding the independent accountant's participation in the due diligence efforts to make clear that such participation will be by independent accountants other than from the Fund's independent accounting firm providing the Fund's audit. Page 5-10 13. In your response letter, undertake to include in any prospectus supplement, as applicable, under a section captioned "Additional Underwriter Compensation" a description of the terms of any agreement that the Fund will have entered into with the underwriters for services other than share distribution, and specify the nature of the services that the underwriter has provided or will provide thereunder that differ from typical underwriting services. Please undertake to disclose whether any such fee payable thereunder is a one-time fee or whether it is payable annually, and undertake to file all such agreements as exhibits in a post-effective amendment to the registration statement. Any underwriting contract should be filed by amendment. Part C 14. Please file as an exhibit the legality opinion regarding all securities being registered, and related consent of counsel, with your next pre- effective amendment. In this regard, since the terms of the actual offerings from this registration statement appear to be uncertain and not yet authorized by the Company's Board of Directors, the Company may need to undertake to file an unqualified legality of shares opinion, and any necessary appropriateness and accuracy of the method used in valuing securities, and make any necessary adjustments".

consents, in a post-effective amendment with each takedown from this shelf registration statement. See Rule 462(d) under the 1933 Act. General 15. Confirm to the staff in your response letter that the Company will submit any underwritten offering to FINRA for its prior approval of the underwriting terms. 16. We may have additional comments on disclosures made in response to this letter, on information supplied supplementally, or on exhibits added in any pre-effective amendments. 17. Response to this letter should be in the form of a pre-effective amendment filed pursuant to Rule 472 under the Securities Act. The pre- effective amendment filing should be accompanied by a supplemental letter that includes your responses to each of these comments. Where no change will be made in the filing in response to a comment, please indicate this fact in your supplemental letter and briefly state the basis for your position. You should review and comply with all applicable requirements of the federal securities laws in connection with the preparation and distribution of a preliminary prospectus. 18. Please advise us if you have submitted or expect to submit an exemptive application or no-action request in connection with your registration statement. ****** We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filings reviewed by the staff to be certain that they have provided all information investors require for an informed decision. Since the Fund and its management are in possession of all facts relating to the fund's disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made. Notwithstanding our comments, in the event the Fund requests acceleration of the effective date of the pending registration statement, it should furnish a letter, at the time of such request, acknowledging that

should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Fund from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and the Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. In addition, please be advised that the Division of Enforcement has access to all information you provide to the staff of the Division of Investment Management in connection with our review of your filing or in response to our comments on your filing. We will consider a written request for acceleration of the effective date of the registration statement as a confirmation of the fact that those requesting acceleration are aware of their respective responsibilities. We will act on the request and, pursuant to delegated authority, grant acceleration of the effective date. ****** Should you have any questions regarding this letter, please contact me at (202) 551-6966. Sincerely, Kevin C. Rupert Accountant

Show Raw Text
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.20S49
DIVISION OF
INVESTMENT MANAGEMENT
February 14, 2013
David Hearth, Esq.
Paul, Hastings, Janofsky & Walker LLP
55 Second Street, 24th Floor
San Francisco, California 94105-3441
RE: Firsthand Technology Value Fund, Inc. ("Fund")
File Nos.: 333-186158 and 814-00830
Dear Mr. Hearth:
The Fund filed a shelf registration statement on January 23, 2013
under which it may offer up to $10,000,000 of its common stock
("Securities") under the Securities Act of 1933 ("1933 Act"). The Fund is a
business development company ("BDC") regulated under the Investment
Company Act of 1940 ("1940 Act"). The Fund expects to file a pre-effective
amendment to the registration statement that will increase the total offering
price of the shares covered by the registration statement. The Securities
may be offered at prices and on terms to be disclosed in one or more
supplements to this prospectus.
Your letter represented that the registration did not contain any
material changes from the disclosure included in the Fund's shelf registration
statement on Form N-2 (File No. 333-179606), initially filed with the
Commission on February 21, 2012 and declared effective, as amended, on
April 19, 2012 ("Old Registration"), except for the soon to be completed
inclusion of audited financial statements and related financial data for the
fiscal year ended December 31, 2012. The registration statement makes
non-material disclosure changes for various purposes including disclosure of
updated portfolio holdings, business activities and market information, such
as net asset value and stock price as of a more recent date. Your letter
further states that there are no problem areas warranting special attention
and there are no new investment techniques or policies disclosed in the
registration statement.
Pursuant to Securities Act Release No. 6510 and in reliance upon the
representations contained in your letter of February 5, 2013, we performed
a limited review of the Fund's registration statement. Whenever a comment
is made in one location, you should consider it applicable to all similar

disclosure appearing elsewhere in the registration statement (including all
future prospectus supplements). We have the following comments.
1. We note that material portions of the filing are incomplete and that
most exhibits and the financial statements are omitted. We may have
additional comments on such portions when you complete them in a pre-
effective amendment, on disclosures made in response to this letter, on
information supplied supplementally, or on exhibits added in any pre-
effective amendments.
Cover Page
2. The Fund intends to invest at least 80% of its total assets in equity
securities of technology companies. However, a Form 8-K filed on January
14 contains a press release issued by the Fund that states "(tJhe Fund also
announced that, as of December 31, 2012, preliminary gross assets of the
Fund were approximately $197 million, or $23.03 per share, including cash
of approximately $15.99 per share". Thus, since it appears that the Fund
held approximately 69% of its assets in cash, please explain how the Fund
will comply with its 80% test, especially in view of its potential cash increase
from the proceeds of this offering. The "Use of Proceeds" section on page 18
should be expanded accordingly.
3. The staff notes that some equity positions held by the Fund may be
subject to extensive speculation with regard to future potential for an initial
public offering. This public speculation may cause Fund's shares to trade at
significant premiums immediately prior to a portfolio company's initial public
offering. This would appear to occur when Fund shares are used as a
surrogate for portfolio company shares. However, once the shares of the
portfolio company become widely available to the public, any premium that
the Fund trades at may be reduced or eliminated. Please be aware that
depending on the Fund's market premium and the depth of public
speculation regarding its portfolio companies, the Fund may need to add
disclosure similar to that on the cover page of the Old Registration1. Please
1 The cover page of the Old Registration states, "(aJs of March 31, 2012, our shares traded at a
significant premium to our net asset value per share. However, only relatively recently the Company's
common stock had traded at a substantial discount to its net asset value. If our premium decreases
after this offering, investors who purchase shares in this offering would experience losses. The
premium may also be reduced or eliminated if and when certain of our portfolio companies complete
initial public offerings. As of December 31, 2011, our net asset value per share was $23.92 per share.
Assuming a public offering price of $34.79 per share, which was the last reported sales price for our
common stock on the NASDAQ Global Market on April 16, 2012, purchasers in this offering will
experience immediate and substantial dilution in net asset value of approximately $8.37 per share.
See "Dilution" for more information. In addition, the companies in which we invest are subject to
special risks."
2

explain in your response letter how the Fund will address/monitor this issue
in its prospectus supplements.
Page 7
4. The table on this page has a column captioned "Percent of Long-Term
Investments" with respect to the Fund's top five equity holdings. This
presentation appears to eliminate the Fund's large cash position. Thus, it
might give the appearance that the top five holdings are a more significant
part of the Fund's investment portfolio than they actually are. Please revise
the disclosure to take into account the Fund's cash position.
Page 12
5. Substitute the word "do" for the word "may" in the last sentence of the
last paragraph on this page.
Page 14
6. Please ensure that in any prospectus supplement the Example will be
adjusted for any sales load.
Page 16
7. The Fund should provide some cautionary footnote language for
investors as to the strong probability that it will be unlikely to maintain such
large premiums to NAV in the future (e.g., 93.9% and 64.9%) with respect
to the chart on this page.
Page 22
8. If true, insert the term "equity" before the word "securities" in the first
sentence of the third full paragraph discussing valuation.
Page 37
9. Please inform the staff whether the Board will review and approve in
advance the valuation methodology of any third-party pricing service it uses
and confirm that the Board will regularly review the historical accuracy of its
fair value methodologies. See Release No. IC-26299; "Compliance Programs
of Investment Companies and Investment Advisers," (December 17, 2003)2.
2 The Release states that Rule 38a- 1 requires Funds to provide a methodology or methodologies by
which the fund determines the current fair value of the portfolio security, and to "regularly review the
3

Page 43
10. Please explain the caption and disclosure for "companies that have
developed leading market positions within their respective markets" in light
of the Fund's stated exposure to micro-cap companies. Revise and develop
the disclosure as needed.
11. Expand the disclosure related to the penultimate sentence of the last
paragraph to explain why the Fund believes strategic sales are more likely
than initial public offerings.
Page 44
12. Please revise the disclosure regarding the independent accountant's
participation in the due diligence efforts to make clear that such participation
will be by independent accountants other than from the Fund's independent
accounting firm providing the Fund's audit.
Page 5-10
13. In your response letter, undertake to include in any prospectus
supplement, as applicable, under a section captioned "Additional Underwriter
Compensation" a description of the terms of any agreement that the Fund
will have entered into with the underwriters for services other than share
distribution, and specify the nature of the services that the underwriter has
provided or will provide thereunder that differ from typical underwriting
services. Please undertake to disclose whether any such fee payable
thereunder is a one-time fee or whether it is payable annually, and
undertake to file all such agreements as exhibits in a post-effective
amendment to the registration statement. Any underwriting contract should
be filed by amendment.
Part C
14. Please file as an exhibit the legality opinion regarding all securities
being registered, and related consent of counsel, with your next pre-
effective amendment. In this regard, since the terms of the actual offerings
from this registration statement appear to be uncertain and not yet
authorized by the Company's Board of Directors, the Company may need to
undertake to file an unqualified legality of shares opinion, and any necessary
appropriateness and accuracy of the method used in valuing securities, and make any necessary
adjustments".
4

consents, in a post-effective amendment with each takedown from this shelf
registration statement. See Rule 462(d) under the 1933 Act.
General
15. Confirm to the staff in your response letter that the Company will
submit any underwritten offering to FINRA for its prior approval of the
underwriting terms.
16. We may have additional comments on disclosures made in response to
this letter, on information supplied supplementally, or on exhibits added in
any pre-effective amendments.
17. Response to this letter should be in the form of a pre-effective
amendment filed pursuant to Rule 472 under the Securities Act. The pre-
effective amendment filing should be accompanied by a supplemental letter
that includes your responses to each of these comments. Where no change
will be made in the filing in response to a comment, please indicate this fact
in your supplemental letter and briefly state the basis for your position. You
should review and comply with all applicable requirements of the federal
securities laws in connection with the preparation and distribution of a
preliminary prospectus.
18. Please advise us if you have submitted or expect to submit an
exemptive application or no-action request in connection with your
registration statement.
******
We urge all persons who are responsible for the accuracy and
adequacy of the disclosure in the filings reviewed by the staff to be certain
that they have provided all information investors require for an informed
decision. Since the Fund and its management are in possession of all facts
relating to the fund's disclosure, they are responsible for the accuracy and
adequacy of the disclosures they have made.
Notwithstanding our comments, in the event the Fund requests
acceleration of the effective date of the pending registration statement, it
should furnish a letter, at the time of such request, acknowledging that
5

should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filing;
the action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Fund
from its full responsibility for the adequacy and accuracy of the
disclosure in the filing; and
the Company may not assert this action as defense in any proceeding
initiated by the Commission or any person under the federal securities
laws of the United States.
In addition, please be advised that the Division of Enforcement has
access to all information you provide to the staff of the Division of
Investment Management in connection with our review of your filing or in
response to our comments on your filing.
We will consider a written request for acceleration of the effective date
of the registration statement as a confirmation of the fact that those
requesting acceleration are aware of their respective responsibilities. We will
act on the request and, pursuant to delegated authority, grant acceleration
of the effective date.
******
Should you have any questions regarding this letter, please contact
me at (202) 551-6966.
Sincerely,
Kevin C. Rupert
Accountant
6